PBS listing for Zytorvi®* (toripalimab), the first and only immunotherapy for a rare type of head and neck cancer
Melbourne, Australia / Hyderabad, India, December 02, 2025 – Dr. Reddy’s Laboratories Ltd., today welcomes the Pharmaceutical Benefits Scheme (PBS) listing of Zytorvi®* (toripalimab), the first and only immunotherapy for nasopharyngeal cancer1-4 (a rare and aggressive type of head and neck cancer).
From 1st December 2025, Zytorvi®* – a next generation PD-1 inhibitor – will be available on the PBS for eligible Australians*. It is indicated as a first-line treatment option in combination with chemotherapy for nasopharyngeal cancer that has returned or spread, and as a single treatment option when the cancer has progressed during treatment with a certain type of chemotherapy or following it.2-3 Administered as an injection, Zytorvi® works by helping the immune system better recognise and fight cancer.2
The Federal Government's subsidy for Zytorvi® is a significant milestone in improving access to innovative treatments for Australians with rare cancers. Despite advances in immunotherapy and targeted medicines over the past decade, people living with rare head and neck nasopharyngeal cancer previously had only traditional treatment options available to them, including radiation, chemotherapy, and invasive surgery.5
___________________________________
Nadia Rosin, CEO of Head and Neck Cancer Australia, the national peak body supporting people affected by head and neck cancer said, "Being diagnosed with head and neck cancer is an overwhelming and devastating experience. Unlike many other cancers, Head and Neck Cancer cannot always be concealed. The effects of treatment are visible to the world, often changing the way someone looks, eats, speaks and interacts with others. This can be deeply isolating, with many people withdrawing from social situations or unable to return to work because of ongoing challenges. The emotional and financial toll can be as significant as the physical one.”
“It takes a team of people to look after someone with Head and Neck Cancer – while a surgeon or oncologist is responsible for getting rid of the cancer, recovery can be long and people rely on a team of specialist nurses, speech pathologists and dietitians to make sure they have the best possible outcomes,” Nadia adds.
